Anesthesia Management During Cardiopulmonary Bypass: Volatile vs. Intravenous Drugs

被引：0
作者：
Nigro Neto C. [1 ]
Landoni G. [2 ]
Bezerra F.J.L. [1 ]
Maranhão Cardoso T.A.A. [1 ]
dos Santos Silva C.G. [1 ]
Stahlschmidt A. [1 ]
机构：
[1] Anesthesiology Department, Dante Pazzanese Institute of Cardiology, Av. Dr. Dante Pazzanese, 500, Sao Paulo
[2] San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan
来源：
Current Anesthesiology Reports | 2017年 / 7卷 / 3期
关键词：
Air pollution; Awareness; Cardiac anesthesia; Cardiopulmonary bypass; Desflurane; Inhalational anesthesia; Isoflurane; Myocardial protection; Oxygenator; Propofol; Sevoflurane; TIVA; Volatile agents;
D O I：
10.1007/s40140-017-0222-9
中图分类号：
学科分类号：
摘要：
Anesthetic management during cardiopulmonary bypass (CPB) is challenging in many aspects. Evidence of mortality reduction due to the use of volatile agents during cardiac surgery has led to their increased use in CPB. Partly because of the difficulty to administer volatile agents during CPB, total intravenous anesthesia (TIVA) has become the most popular technique used by cardiac anesthetists throughout this critical period. The aim of this review is to provide an overview of volatile agents’ administration to ensure maintenance of adequate depth of anesthesia during CPB and weighting risks and benefits of this technique compared to TIVA. © 2017, Springer Science+Business Media, LLC.
引用
收藏
页码：299 / 305
页数：6
相关论文
共 34 条
  • [1] Norden I., The influence of anaesthetics on systemic vascular resistance during cardiopulmonary bypass, Scand J Thorac Cardiovasc Surg, 8, pp. 81-87, (1974)
  • [2] Landoni G., Rodseth R.N., Santini F., Et al., Randomized evidence for reduction of perioperative mortality, J Cardiothorac Vasc Anesth, 26, pp. 764-772, (2012)
  • [3] De Hert S.G., Vander Linden P.J., Cromheecke S., Et al., Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration, Anesthesiology, 101, pp. 299-310, (2004)
  • [4] Nussmeier N.A., Moskowitz G.J., Weiskopf R.B., Et al., In vitro anesthetic washin and washout via bubble oxygenators: influence of anesthetic solubility and rates of carrier gas inflow and pump blood flow, Anesth Analg, 67, pp. 982-987, (1988)
  • [5] McMullan V., Alston R.P., Tyrrell J., Volatile anaesthesia during cardiopulmonary bypass, Perfusion, 30, 1, pp. 6-16, (2015)
  • [6] Langbein T., Sonntag H., Trapp D., Et al., Volatile anaesthetics and the atmosphere: atmospheric life times and atmospheric effects of halothane, enflurane, isoflurane, desflurane and sevoflurane, Br J Anaesth, 82, pp. 66-73, (1999)
  • [7] Yasny J.S., White J., Environmental implications of anesthetic gases, Anesth Prog, 59, pp. 154-158, (2012)
  • [8] Nigro Neto C., Arnoni R., Rida B.S., Landoni G., Tardelli M.A., Randomized trial on the effect of sevoflurane on polypropylene membrane oxygenator performance, J Cardiothorac Vasc Anesth, 27, 5, pp. 903-907, (2013)
  • [9] Nigro Neto C., De Simone F., Cassara L., Silva C.G.S., Cardoso T.A.A.M., Carco F., Et al., Tricks, tips, and literature review on the adapted vaporize system to deliver volatile agents during cardiopulmonary bypass, Ann Card Anaesth, 19, 2, pp. 240-244, (2016)
  • [10] Lim H.S., Cho S.H., Kim D.K., Et al., Isoflurane cracks the polycarbonate connector of extra-corporeal circuit: a case report, Korean J Anesth, 58, pp. 304-306, (2010)
1234